Sanofi reports amlitelimab improved lung function in asthma, with new phase 3 trials planned across its respiratory pipeline.

Two-thirds of Americans report spring allergies, and about 4 in 10 say they take an allergy medication several times a week. But those medicines, while valuable, don’t exactly fix the problem. One ...

Eyestem Research, a Bangalore-based cell therapy company, is pleased to announce significant vision improvement in Phase 1 trials of its investigational drug, Eyecyte-RPEtm, in patients with ...

Allergy & Asthma Network is teaming up with Right2Breathe to bring vital lung health education and free asthma and COPD screenings to motorsport enthusiasts across the country this year. The ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Meeting is the largest gathering of competition, consumer protection, and data privacy profes­sionals globally, with lawyers, ...

Osteoarthritis is a common chronic health condition that is characterised by joint pain and restricted movement. The main ...

The same biological processes that drive aging — such as energy loss — may also contribute to lung diseases like chronic ...

China’s investments in renewables in Kazakhstan allow Chinese companies to export their excess capacities to profitable foreign markets but also help China mask its environmental damage and create a ...

The global lung disease therapeutics market is on an impressive growth trajectory, projected to soar to USD 152,369.26 million by 2033, up from USD 83,398.60 million in 2023. This significant increase ...

Discover the latest drugs and treatment options in the Psoriasis Pipeline. Dive into DelveInsight's comprehensive report ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...